Medicine & Life Sciences
HIV
100%
CD4 Lymphocyte Count
49%
Therapeutics
38%
Reverse Transcriptase Inhibitors
35%
Neutralizing Antibodies
31%
Biomarkers
28%
Consent Forms
27%
HIV-1
27%
Acquired Immunodeficiency Syndrome
27%
Placebos
26%
Drug Resistance
26%
Subcutaneous Tissue
25%
Cardiovascular Diseases
23%
Random Allocation
23%
Protease Inhibitors
22%
Monoclonal Antibodies
21%
SARS Virus
20%
Lamivudine
19%
Body Composition
18%
High-Throughput Nucleotide Sequencing
18%
Interleukin-6
16%
Zidovudine
16%
efavirenz
16%
GS-5734
16%
Stavudine
15%
lamivudine drug combination abacavir
15%
Inpatients
15%
Disease Progression
15%
HIV Infections
14%
Confidence Intervals
14%
Demography
13%
Inflammation
13%
Self Report
13%
Malus
12%
Safety
12%
Serum Amyloid A Protein
12%
Medical Futility
12%
Coronavirus
12%
Hispanic Americans
11%
Informed Consent
11%
Clinical Trials
11%
RNA
11%
Infections
11%
Viremia
10%
Highly Active Antiretroviral Therapy
10%
Medication Adherence
10%
Randomized Controlled Trials
9%
HLA Antigens
9%
Serum Albumin
9%
Risk-Taking
9%